SIGMAR1 and Parkinson disease: The aim of the present study was to determine the role of Sigma1Rs in the afobazole-mediated normalizing effect on dopamine content in the striatum in an in vivo mouse model of Parkinson’s disease induced by 6-OHDA lesions.